文献

J-GLOBAL ID：201702261696847311   整理番号：17A1051264

心不全による入院患者の院内死亡率に対するカルペリチドの効果:傾向スコア分析

Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses

著者 (6件)： OGISO Masataka (Tokyo Metropolitan Tama Medical Center, Tokyo, JPN) ,  ISOGAI Toshiaki (Tokyo Metropolitan Tama Medical Center, Tokyo, JPN) ,  OKABE Yuta (Tokyo Metropolitan Tama Medical Center, Tokyo, JPN) ,  ITO Kansuke (Tokyo Metropolitan Tama Medical Center, Tokyo, JPN) ,  TSUJI Masaki (Tokyo Metropolitan Tama Medical Center, Tokyo, JPN) ,  TANAKA Hiroyuki (Tokyo Metropolitan Tama Medical Center, Tokyo, JPN)
資料名： Heart and Vessels  (Heart and Vessels)
巻： 32  号： 8  ページ： 916-925  発行年： 2017年08月 
JST資料番号： X0101A  ISSN： 0910-8327  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 心房性ナトリウム利尿ペプチド(カルペリチド)の使用が心不全患...

シソーラス用語： *ANP【ペプチド】 ,...
準シソーラス用語： *院内死亡率 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1051264&from=J-GLOBAL&jstjournalNo=X0101A") }}

分類 (2件)： 心臓作用薬の臨床への応用  (GW07030Y) ,  循環系疾患の薬物療法  (GJ05020M)

物質索引 (1件)： カルペリチド

引用文献 (34件)：

• Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 62(16):e147-e239
• McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. developed in collaboration with the Heart failure association (HFA) of the ESC. Eur J Heart Fail 14:803-869
• Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, Sonoda R, Ban T, Yasue H, Imura H (1987) Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76:115-124
• Kangawa K, Matsuo H (1984) Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 118:131-139
• Ozawa T, Shinke T, Shite J, Takaoka H, Inoue N, Matsumoto H, Watanabe S, Yoshikawa R, Otake H, Matsumoto D, Ogasawara D, Yokoyama M, Hirata K (2015) Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction. J Cardiol 66:232-238

タイトルに関連する用語 (6件)： 心不全 ,  入院患者 ,  院内死亡率 ,  カルペリチド ,  傾向スコア ,  分析